IFNA1 and Familial prostate cancer: To confirm the presence of these mutations in our batch of LNCaP cells, we extracted the genomic DNA from LNCaP and DU145 cells (the latter prostate cancer cell line served as a positive control since it is IFN-sensitive [17]).